To compare the effects on body composition and muscle strengthof 54-weeks treatment with of testosterone undecanoate combined with placebo or with the 5a-reductase inhibitor dutasteride
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in isokinetic knee extension and flexion peak torque (PT-IKE and PT-IKF)
Timeframe: At baseline and after 54 weeks of treatment
Change in handgrip strength
Timeframe: At baseline and after 54 weeks of treatment
Change in body composition
Timeframe: At baseline and after 54 weeks of treatment
Change in bone mineral density
Timeframe: At baseline and after 54 weeks of treatment
Change in anthropometric assessment: BMI
Timeframe: At baseline and after 54 weeks of treatment
Change in anthropometric assessment: waist-to-hip ratio
Timeframe: At baseline and after 54 weeks of treatment